Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03310333
Other study ID # CHU-352
Secondary ID 2017-A00811-52
Status Recruiting
Phase Phase 4
First received September 27, 2017
Last updated February 15, 2018
Start date February 14, 2018
Est. completion date July 1, 2020

Study information

Verified date February 2018
Source University Hospital, Clermont-Ferrand
Contact Patrick LACARIN
Phone 04 73 75 11 95
Email placarin@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective is to demonstrate the superiority of the strategy of labor induction by Cook® cervical ripening balloon between recommended strategy by dinoprostone (propess®) on the reduction of the time between cervical ripening and delivery in case of unfavorable cervix after 12 hours of PROM in term pregnant women.


Description:

The inclusion begins after 12 hours of PROM for a pregnant woman who has an unfavourable cervix and no B streptococcus. The case is discussed during the obstetric staff every morning.

If the cervix is unfavourable (cervical Bishop's score <6), the information of the study is given to the patient and the consent collected.

An antibiotic is started at the beginning of the inclusion by amoxicillin (or clindamycin in case of allergy of amoxicillin) to prevent choroamnionitis.

After randomization, the patient is included in one of the two groups: Cook ® balloon or Propess ®.

- In the Cook cervical ripening balloon group: the device is introduced by a resident or a doctor. No traction on the probe was done. It is left in place for maximum 12 hours. Oxytocin is added at the end of the first 6 hours even if device is fallen. An epidural analgesia can be started before or after the installation of oxytocin

- In dinoprostone vaginal group: the device is placed in vaginal fornix by the midwife for maximum 24 hours. If Propess ® is fallen before the first 12 hours, another one could be introduce if the cervix stayed unfavourable.

After 24 hours, it is removed. If they are any contraction, oxytocin is started with or without epidural analgesic.

- The fetal heart rate is monitoring 30 minutes before and after the insertion of the device. After, the patient has a monitoring each 6 hours.

- Since the oxytocin is started, the monitoring is registered in continue until the delivery.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date July 1, 2020
Est. primary completion date April 1, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Pregnant women

- 18 years old With a singleton live cephalic pregnancy = 37+0 weeks Gestational age estimated from the first trimester ultrasound (realized between 11 and 13+6 weeks of gestation) PROM without spontaneous labour in the 12 hours after the rupture. The diagnostic of PROM is clinic or biologic (ActimProm® test).

Unfavourable cervix (Bishop's score < 6) Agreement of the patient after clear, loyal and appropriate information Subject covered by or having the rights to the French Social Security system

Exclusion Criteria:

- Vaginal infection by B streptococcus or in urinary sample during actual or anterior pregnancy Meconium fluid amniotic Contraindication of vaginal delivery (placenta praevia, …) Temperature > 38,2°C Suspicion of chorio-amnionitis among Newton requirements Intra-uterine growth restriction < 3rd percentile with Doppler abnormalities History of cesarean and uterine scare Suspected genital herpes infection Known VIH seropositivity (confirmed by blood serology) Fetus with suspected severe congenital abnormalities Pathological fetal heart rate (see appendix 1) Contra-indications to Propess®, Cook® Cervical Ripening Balloon, Oxytocin Women under guardianship or trusteeship

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Propess® (dinoprostone)
The inclusion begins after 12 hours of PROM for a pregnant woman who has an unfavourable cervix and no B streptococcus. The case is discussed during the obstetric staff every morning. If the cervix is unfavourable (cervical Bishop's score <6), the information of the study is given to the patient and the consent collected. An antibiotic is started at the beginning of the inclusion by amoxicillin (or clindamycin in case of allergy of amoxicillin) to prevent choroamnionitis.
Device:
cook cervical pipening balloon
• In dinoprostone vaginal group: the device is placed in vaginal fornix by the midwife for maximum 24 hours. If Propess ® is fallen before the first 12 hours, another one could be introduce if the cervix stayed unfavourable.

Locations

Country Name City State
France CHU Clermont-Ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time between the beginning of the induction of labor and the delivery at day 1
Secondary Time limits between the PROM and the beginning of induction at day 1
Secondary Rate of delivery in the first 24 hours at day 1
Secondary Application time of Cook® balloon at day 1
Secondary Application time of Propess® at day 1
Secondary Time between labour induction and vaginal delivery at day 1
Secondary Rate of vaginal delivery with and without extraction at day 1
Secondary Rate of cesarean at day 1
Secondary Rate of delivery hemorrhage at day 1
Secondary Bischop score when Cook balloon is fallen or retry at day 1
Secondary Rate of balloon present after 12 hours at day 1
Secondary Rate of anomaly of fetal heart rate leading stop of dinoprostone at day 1
Secondary Rate of epidural analgesia at day 1
Secondary Time to obtain active labour at day 1
Secondary Time to obtain complete cervix dilatation at day 1
Secondary Rate of fever during the labour at day 1
Secondary Rate of uterine hyperkinesias at day 1
Secondary Rate of clinic chorio-amnionitis defined by Newton criteria at day 1